𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors

✍ Scribed by Steffen Walter; Gilles Bioley; Hans-Jörg Bühring; Sven Koch; Dorothee Wernet; Alfred Zippelius; Graham Pawelec; Pedro Romero; Stefan Stevanović; Hans-Georg Rammensee; Cécile Gouttefangeas

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
324 KB
Volume
35
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improved detection of melanoma antigen-s
Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogue
✍ Markus J. Maeurer; Antje Necker; Russell D. Salter; Chiara Castelli; Hanni Höhn; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 213 KB

## Abstract MHC class I tetramers containing peptide epitopes are sensitive tools for detecting antigen‐specific CD8^+^ T‐cell responses. We demonstrate here that binding of HLA‐A2 tetramers to CD8^+^ T cells specific for the melanoma‐associated antigen Melan‐A/MART‐1 can be fine‐tuned by altering

A subpopulation of CD8+ T cells specific
A subpopulation of CD8+ T cells specific for melanocyte differentiation antigens expresses killer inhibitory receptors (KIR) in healthy donors: evidence for a role of KIR in the control of peripheral tolerance
✍ Bertrand Huard; Lars Karlsson 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

In cancer patients, NK cell inhibitory receptors (IR) are expressed on a fraction of melanomaspecific lymphocytes with a unique reactivity for tumor antigens derived from normal, nonmutated genes (differentiation antigens). It is presently not known whether expression of these receptors is induced d

CD80 expression in an HLA-A2-positive hu
CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer
✍ Dale L. Bixby; John R. Yannelli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB 👁 2 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix